Veterinary Medicines

RONAXAN 500 MG/G

Authorised
  • Doxycycline hyclate
Download as PDF

Product identification

Medicine name:
RONAXAN 500 MG/G
Active substance:
  • Doxycycline hyclate
Target species:
  • Turkey
  • Pig
  • Cattle (calf)
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Doxycycline hyclate
    577.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Turkey
      • Meat and offal
        6
        day
    • Pig
      • Meat and offal
        6
        day
    • Cattle (calf)
      • Meat and offal
        14
        day
    • Chicken
      • Meat and offal
        4
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dopharma France S.A.S.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma France
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/6903191 9/2014
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."